Stay updated on T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.

Latest updates to the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page
- Check7 days agoChange DetectedA new Revision: v3.6.4 appears in the study record history, and Revision: v3.6.3 is removed. This update reflects an update to the record's version history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new page revision is recorded (v3.6.3) replacing the earlier revision (v3.6.2) in the study's history. This reflects an update to the page metadata rather than substantive study details.SummaryDifference0.1%

- Check35 days agoChange DetectedThe revision history now shows a new entry for v3.6.2, replacing the prior v3.6.0 in the study record.SummaryDifference0.1%

- Check50 days agoChange DetectedRecruitment status was updated to 'No longer looking for participants', indicating enrollment has ended. The record history was updated to Revision: v3.6.0, replacing the previous revision (v3.5.5).SummaryDifference0.7%

- Check57 days agoChange DetectedThe history now shows a new software revision entry (v3.5.5) and removes the prior revision (v3.5.4), indicating a new site release was logged.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page history now shows a new revision tag, v3.5.4, added to the study record history. This updates the record with a newer revision, replacing the prior v3.5.3 entry.SummaryDifference0.1%

Stay in the know with updates to T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1 Osimertinib Combo for HER2 in NSCLC Clinical Trial page.